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Abstract
Background: Brain-derived neurotrophic factor (BDNF), which is sorted into a regulated
secretory pathway of neurons, is supposed to act retrogradely through dendrites on presynaptic
neurons or anterogradely through axons on postsynaptic neurons. Depending on which is the case,
the pattern and direction of trafficking of BDNF in dendrites and axons are expected to be
different. To address this issue, we analyzed movements of green fluorescent protein (GFP)-tagged
BDNF in axons and dendrites of living cortical neurons by time-lapse imaging. In part of the
experiments, the expression of BDNF tagged with cyan fluorescent protein (CFP) was compared
with that of nerve growth factor (NGF) tagged with yellow fluorescent protein (YFP), to see
whether fluorescent protein-tagged BDNF is expressed in a manner specific to this neurotrophin.
Results: We found that BDNF tagged with GFP or CFP was expressed in a punctated manner in
dendrites and axons in about two-thirds of neurons into which plasmid cDNAs had been injected,
while NGF tagged with GFP or YFP was diffusely expressed even in dendrites in about 70% of the
plasmid-injected neurons. In neurons in which BDNF-GFP was expressed as vesicular puncta in
axons, 59 and 23% of the puncta were moving rapidly in the anterograde and retrograde directions,
respectively. On the other hand, 64% of BDNF-GFP puncta in dendrites did not move at all or
fluttered back and forth within a short distance. The rest of the puncta in dendrites were moving
relatively smoothly in either direction, but their mean velocity of transport, 0.47 ± 0.23 (SD) µm/
s, was slower than that of the moving puncta in axons (0.73 ± 0.26 µm/s).
Conclusion: The present results show that the pattern and velocity of the trafficking of
fluorescence protein-tagged BDNF are different between axons and dendrites, and suggest that the
anterograde transport in axons may be the dominant stream of BDNF to release sites.
Background
Neurotrophins have been considered to play roles in the
differentiation, neurite outgrowth and survival of a certain
group of neurons [1-4]. In addition to these well-known
functions, most neurotrophins are involved in rapid
changes in the function of neural circuits [5,6]. In particu-
lar, brain-derived neurotrophic factor (BDNF) plays a role
in activity-dependent changes in synaptic function [7-9].
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in the nucleus of neurons is sorted into a regulated secre-
tory pathway through the trans-Golgi network, and trans-
ported to release sites in neurites [10,11]. In axons it is
suggested that BDNF is transported through the fast
axonal flow and then released and transferred to postsyn-
aptic neurons in an activity-dependent manner [10-15].
In dendrites or dendrite-like neurites also, the targeting of
BDNF to distal parts and its release were suggested to
occur in an activity-dependent manner [16-22]. Since
these previous studies were carried out using immunohis-
tochemical and/or in situ hybridization technique after
the fixation of neurons, or by observing the decrease in
fluorescence intensity of neurons expressing BDNF tagged
with green fluorescent protein (GFP), the actual dynamics
of BDNF trafficking was not analyzed in dendrites. Thus,
a question of whether the trafficking of BDNF is different
between axons and dendrites of neurons is not answered
yet.
An answer to this question will give a clue that may
resolve the controversial issue of whether BDNF acts retro-
gradely through dendrites on presynaptic neurons or
anterogradely through axons on postsynaptic neurons. To
address this question, it is desirable to perform a real-time
analysis of movements of BDNF tagged with GFP in both
axons and dendrites of living neurons. However, such an
analysis of BDNF trafficking has not been successfully car-
ried out except for two recent studies on its retrograde
transport in dorsal root ganglion neurons [23] and bidi-
rectional transport in cortical cell neurites [24]. However,
the observation was restricted to axons in the former
study, and axons and dendrites were not distinguished in
the latter study.
In the present study we carried out a real-time analysis of
movements of BDNF tagged with GFP in both axons and
dendrites of living cortical neurons using the method of
direct injection of their plasmid cDNAs into the nucleus
[14]. We found that most of BDNF-GFP moves smoothly
in the anterograde direction in axons while it does not
move in dendrites in most cases. Even if it moves in den-
drites, its velocity is slower than that in axons.
Parts of the present results were published in an abstract
form [25].
Results
Plasmids encoding BDNF tagged with GFP or CFP at the
COOH-terminus were injected into the nucleus of cul-
tured cortical neurons through a micropipette under vis-
ual control, as reported previously [14]. GFP- or CFP-
tagged BDNF resulting from these plasmids were con-
firmed to be biologically active and mimic the releasing
properties of untagged BDNF [20]. In the present experi-
ments, 20–30% of the neurons into which plasmids had
been injected expressed fluorescent signals, as reported
previously [14]. The expression of signals was already
detected 16 h after the injection, but recordings were usu-
ally carried out about 24 h after the injection.
In about two-thirds of the neurons that expressed fluores-
cent signals of BDNF-GFP, the signals were punctated in
clusters along dendrites and axons (Fig. 1A). The soma
and bases of dendritic trunks appeared to be filled with
fluorescent signals because of the very dense expression of
BDNF-GFP. To see whether the distribution of BDNF-GFP
signal was similar to that of endogenous BDNF, neurons
cultured in companion dishes (sister-cultured neurons)
were stained immunocytochemically with antibody to
BDNF. The distribution of endogenous BDNF was also
punctated in neurites and diffuse in the soma (Fig. 1B), as
reported previously (14, 19, 20). This distribution pattern
was similar to that of granular BDNF-GFP, suggesting that
BDNF-GFP was expressed in plasmid-injected neurons in
a similar way to endogenous BDNF if the expression in
neurites was granular. In about one-third of the neurons
that expressed fluorescence, the signals were diffuse and
smear-like even in dendrites. These neurons were not
included in the analysis of BDNF-GFP trafficking.
In the present study we attempted to inject plasmids into
pyramidal cell-like neurons which are excitatory. To con-
firm that neurons expressing fluorescent signals were exci-
tatory, they were stained immunocytochemically with
anti-glutamic acid decarboxylase 65 (GAD65) antibody.
As shown in Figure 1C and 1D, a neuron that expressed
BDNF-GFP was not stained with the antibody. This was
confirmed by the superposition of the two images (Fig.
1E). This result suggests that the BDNF-GFP-injected cell
was an excitatory neuron. All of the 12 BDNF-GFP-
injected neurons that were immunocytochemically tested
were negative to anti-GAD65 antibody, indicating that the
neurons analyzed in the present study were most likely
excitatory. We also stained neurons by immunocytochem-
istry using anti-microtubule-associated protein 2 (MAP2)
antibody to differentiate axons from dendrites. As shown
in Figure 1F–I, we could identify axons on the basis of
their negativity to anti-MAP2 antibody (arrowheads in
Fig. 1F, H and 1I). Fluorescent signals were detected also
in MAP2-negative neurites (Fig. 1H and 1I), indicating
that BDNF-GFP was expressed in axons as well as soma-
todendritic regions.
In part of the experiments we injected plasmids encoding
NGF-GFP to see whether BDNF-GFP is expressed in a
manner specific to this neurotrophin. The granular expres-
sion of NGF-GFP was seen in a minor group of the cells
that expressed fluorescent signal (see Fig. 2E). In most of
the cells NGF-GFP was expressed in a smear-like mannerPage 2 of 10
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Similar distribution of BDNF-GFP and endogenous BDNF, and expression of BDNF-GFP in GAD65-negative neurons and its 
localization in axons and somatodendritic regions. A, BDNF-GFP expressed in a neuron 24 h after plasmid cDNA encoding 
BDNF-GFP was injected into the nucleus. Scale bar in A and B indicates 50 µm B, Immunocytochemical image of another, non-
injected neuron stained with anti-BDNF antibody. C, Image of neurons expressing and not-expressing BDNF-GFP. Scale bar 
indicates 50 µm and applies to D and E. D, Image of the neurons shown in C, immunocytochemically stained with anti-GAD65 
antibody. E, Superimposed images of C and D. F, Distribution of BDNF-GFP expressed in another neuron. Arrowheads indi-
cate a MAP2-negative neurite. Scale bar indicates 50 µm and applies to G and H. G, Image of the same neuron as shown in F, 
immunocytochemically stained with anti-MAP2 antibody. H, Superimposed images of F and G. I, Magnified image of the boxed 
area in H. Vesicular puncta of BDNF-GFP in the axon are seen more clearly than those in H.Page 3 of 10
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BMC Neuroscience 2005, 6:42 http://www.biomedcentral.com/1471-2202/6/42even in dendrites. To exclude a possibility that such a dif-
ference in the expression pattern between the two neuro-
trophins tagged with GFP might reflect cell-to-cell
variability, we simultaneously injected a combination of
plasmids, BDNF-CFP and NGF-YFP into the nucleus of a
single neuron. For this purpose CFP or YFP was used in
place of GFP, because the fluorescent wavelength of GFP
overlaps with that of CFP or YFP, but those of CFP and
YFP do not substantially overlap with each other. As in the
case of single injection, BDNF-CFP was expressed mostly
in a granular manner while NGF-YFP was expressed in a
smear-like manner in the same cell. An example for this
finding is shown in Figure 2A–C. Many puncta of BDNF-
CFP were seen along neurites while NGF-YFP was seen in
a smear-like manner in the neurites of the same cell. Such
a difference in expression pattern between the two neuro-
trophins was evident in the superimposed figure (Fig. 2C).
The results obtained with simultaneous expression of the
Simultaneous expression of BDNF-CFP and NGF-YFP in the same neuron and proportion of neurons with granular expression of fl orescent punctaFig re 2
Simultaneous expression of BDNF-CFP and NGF-YFP in the same neuron and proportion of neurons with granular expression 
of fluorescent puncta. A, Image of a neuron expressing BDNF-CFP. Scale bar indicates 50 µm and applies to B and C. B, Image 
of the same neuron as in A, expressing NGF-YFP. C, Superimposed images of A and B. D, Proportion of neurons with granular 
expression of fluorescent puncta. Numerators at the right end of bar indicate the number of neurons showing granular expres-
sion of each neurotrophin tagged with CFP or YFP, and denominators indicate the total number of cells which expressed both 
fluorescent signals. E, Mean proportions of neurons with granular expression of fluorescent puncta, obtained from all the data 
including those obtained with the single injection of plasmid cDNAs. Numbers at the right end of bar indicate the number of 
injection trials, in which 4–10 neurons expressed fluorescent signals. Horizontal lines at the end of bars indicate 2SEMs.Page 4 of 10
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BMC Neuroscience 2005, 6:42 http://www.biomedcentral.com/1471-2202/6/42two neurotrophins are summarized in Figure 2D. As seen
in this graph, about 60% of the cells expressed CFP-tagged
BDNF in a vesicular manner while only about 20% of the
cells expressed YFP-tagged NGF in such a manner.
As mentioned before, the single injection of plasmid
cDNAs encoding GFP-, CFP- or YFP-tagged neurotrophins
also showed the difference in the expression pattern
between BDNF and NGF (Fig. 2E). In this analysis the pro-
portion of cells with vesicular expression was calculated
for each session of injection trials and then the mean val-
ues were calculated from 21 and 20 sessions of trials for
fluorescent protein-tagged BDNF and NGF, respectively.
The means ± SEMs were 71.2 ± 1.5 and 29.2 ± 5.0%,
respectively. The difference between these two values was
statistically significant (P <0.001, unpaired t-test). These
results indicate that the granular expression of BDNF-GFP
was not common to other neurotrophins, although we
did not observe the expression of fluorescent protein-
tagged neurotrophin-3 and neurotrophin-4/5 in the
present study.
We then found that most of the fluorescent puncta were
moving in neurites of living neurons in the anterograde as
well as retrograde directions (see Additional file 1). The
movements of puncta were observed in about 80% of the
neurons that showed a vesicular expression of BDNF-GFP.
Neurons in which moving puncta were not detected were
excluded from the analysis of BDNF-GFP trafficking. A
detailed observation indicated that most of the puncta in
axons moved smoothly in the anterograde direction,
while most of the puncta in dendrites did not move or
moved back and forth within a small distance in a flutter-
ing manner. Figures 3B and 3C show an example of such
observations. In an axon of a neuron shown in Figure 3B,
a bright vesicle was observed to move in the anterograde
direction at an almost constant velocity (punctum c) and
another vesicle (punctum b) started to move about 10 s
later (see also time-lapse pictures in Additional file 1). A
small number of vesicles did not move during the obser-
vation time (punctum a). In dendrites, a substantial
number of vesicles did not move (punctum c of Fig. 3C),
but some puncta suddenly moved in the distal direction
and then moved back to the original point (punctum a).
We also found that a few puncta in dendrites moved ini-
tially, and then suddenly stopped and stayed in the same
position during the observation time, as shown in Figure
3C (punctum b). These observations were carried out up
to about 200 µm from the soma. Within this distance we
did not detect a notable regional difference in the traffick-
ing of puncta in dendrites nor in axons.
To quantify these observations we classified fluorescence-
positive puncta into four groups, i.e., puncta moving in
the distal direction over a distance of 10 µm, those mov-
ing in the proximal direction over 10 µm, those not mov-
ing during the observation time of at least 15 min, and
those fluttering within 10 µm. As shown in Figure 4A,
59% of the puncta in axons moved in the distal direction
toward the terminals and only 23% of the puncta in axons
moved in the proximal direction. On the other hand, 64%
of the puncta in dendrites did not move at all or only flut-
tered within the short distance. Nevertheless, the rest of
them in dendrites were observed to move in the distal or
proximal direction. We then calculated the velocity of
moving puncta in axons and dendrites, and found that the
velocity was faster in axons on average than in dendrites.
Figure 4B shows the distribution histograms of the veloc-
ity of moving puncta in axons or dendrites. The mean
velocity of moving puncta in the distal (anterograde)
direction was not markedly different from that in the
proximal (retrograde) direction. Therefore, movements in
both directions were combined in these histograms. The
mean velocity in axons was 0.73 ± 0.26 (SD) µm/s, while
that in dendrites was 0.47 ± 0.23 µm/s. The difference
between these two distributions is evident in the cumula-
tive probability curves of the values (Fig. 4C). The differ-
ence between the two curves was statistically significant
(Kolmogorov-Smirnov test, P < 0.001).
Discussion
In the live-cell imaging of GFP- or CFP-tagged BDNF, we
observed that most of fluorescent protein-tagged BDNF
which were expressed as vesicular puncta in axons moved
rapidly in the anterograde direction, as reported previ-
ously [14]. It is possible to argue that because of the direct
injection of the plasmids into the nucleus of neurons, the
anterograde movements of BDNF-GFP from the soma
were dominant. This possibility seems unlikely, however,
because the movements of BDNF-GFP vesicles in axons
were already observed 16 h after the injection and the ves-
icles were calculated to move over a distance of 20 mm by
the observation time (24 h after the injection) assuming
that the mean velocity of 0.73 µm/s was maintained.
Thus, BDNF-GFP is expected to have reached terminals of
neurites long before the observation time. Indeed we
observed that a substantial proportion of vesicles were
moving in the retrograde direction in axons and dendrites,
as shown in Figure 4A.
BDNF-GFP vesicles were expressed in dendrites as well as
in axons. The number of expressed vesicles in dendrites
was much larger than that in axons. This difference seems
to reflect the difference in areas between dendrites and
axons. Thus, we did not find a strongly polarized expres-
sion of BDNF-GFP in either structural domain of neurons.
In dendrites, however, the trafficking pattern of BDNF-
GFP was markedly different from that in axons. Most of
the BDNF-GFP vesicles in dendrites did not move at all or
just fluttered within a small distance. Only a smallPage 5 of 10
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while most of the puncta in axons moved smoothly over
a long distance. There is a possibility that the directed
movement of the fluorescent vesicles was not seen in den-
drites, because BDNF-GFP had already arrived at dendritic
sites where it was packed for release machinery. This pos-
sibility seems unlikely, since we did not observe a higher
mobility of the puncta in dendrites at 16 h after the injec-
tion than at the standard observation time (24 h after the
injection).
We further found that the velocity of transport of a minor
group of BDNF-GFP puncta in dendrites was slower than
that of BDNF-GFP puncta in axons. The mean velocity in
axons (0.73 ± 0.26 µm/s) is comparable to the reported
values for the anterograde transport of a synaptic vesicle
protein, synaptophysin tagged with GFP, in the axons of
mouse dorsal root ganglion cells (0.69 ± 0.33 µm/s, [26])
and of 125I-labelled BDNF in the optic nerve of neonatal
rats (0.47–0.92 µm/s, [15]). The present observations that
the velocity and the pattern of movements of BDNF-GFP
in dendrites were different from those in axons seem con-
sistent with the previous results that dendrites have micro-
tubules of mixed polarity orientation, while axonal
microtubules have a uniform polarity orientation, with
their plus ends toward the axonal terminal [27] and that
motor proteins, microtubule-based kinesin superfamily
proteins (KIFs), are differentiated in axons and dendrites
[28]. The question of what kinds of KIFs or other motor
proteins are responsible for the difference in the pattern of
trafficking of BDNF-GFP between axons and dendrites
will be clarified in future studies.
In the present study using the plasmid cDNA injection
method, there is a possibility that BDNF-GFP was
expressed at much higher level than that of endogenous
BDNF, and thus the sorting and trafficking characteristics
would be different from those of endogenous BDNF.
Movements of BDNF-GFP puncta in an axon and dendrites of a living neuronFigure 3
Movements of BDNF-GFP puncta in an axon and dendrites of a living neuron. A, Image of a cortical neuron which expressed 
BDNF-GFP in soma, axon and dendrites. Time-lapse images in each square along an axon and a dendrite are magnified and 
shown in B and C, respectively. Scale bar, 50 µm. B, Moving (b and c) and non-moving (a) puncta in the axon. Each image was 
taken at a time point indicated at the top of each figure. Right is the distal side of the axon. Scale bar in the bottom image indi-
cates 5 µm and applies to all the images in B and C. C, Moving (a and b) and non-moving (c) puncta in the dendrite. Right is the 
distal side of the dendrite. Each image was taken at a time point indicated at the top of each figure.Page 6 of 10
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BMC Neuroscience 2005, 6:42 http://www.biomedcentral.com/1471-2202/6/42Properties of movement of BDNF-GFP puncta in axons and dendritesFigure 4
Properties of movement of BDNF-GFP puncta in axons and dendrites. A, A proportion of puncta which move in axons (filled 
columns) or dendrites (open columns) in the distal and proximal directions, do not move, and flutter within a small distance 
(10 µm). The numbers of puncta observed are given in parentheses. B, Distribution of moving puncta with different velocities. 
The bin width of the abscissa was 0.1 µm/s, and 0 indicates that the velocity was slower than 0.1 µm/s. The total numbers of 
vesicles analyzed were 132 in axons and 349 in dendrites. C, Cumulative plots of velocity distributions shown in the histograms 
of B. Dotted and continuous lines represent dendrites and axons, respectively.Page 7 of 10
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we believe that it is unlikely, based on the two
observations. 1) The intracellular localization of
expressed BDNF-GFP is similar to that of endogenous
BDNF when BDNF-GFP is expressed in a punctated man-
ner. 2) As discussed above, the mean velocity of trafficking
of BDNF-GFP in axons is similar to the reported value for
the anterograde transport of 125I-labelled BDNF in the
optic nerve of neonatal rats. This suggests that the traffick-
ing properties of BDNF-GFP are not significantly different
from those of endogenous BDNF. Furthermore we
observed that the expression pattern of BDNF-GFP or -
CFP was different from that of NGF-GFP or -YFP in most
cases. These results altogether suggest that the expression
and trafficking of BDNF-GFP may not be substantially dif-
ferent from those of endogenous BDNF. This further sug-
gests that the GFP tag may not notably affect sorting and
trafficking of secretory proteins, as reported previously
[26].
In sum, the present finding that the anterograde traffick-
ing of BDNF-GFP in axons was dominant in cortical neu-
rons seems consistent with the view that BDNF acts on
postsynaptic neurons in the anterograde direction [13-
15,29-35].
Conclusion
The present results show that the pattern and velocity of
the trafficking of BDNF are different between the two
structural domains of neurons, axons and dendrites, and
suggest that the anterograde transport in axons may be the
dominant stream of BDNF to release sites.
Methods
Culture preparation of neurons
Neonatal mice (C57/BL6, postnatal day 0–1) were anes-
thetized with ketamine (> 30 mg/kg, i.p.), and then killed
by cervical dislocation. The experimental procedures met
the regulation of the Animal Care Committee of Osaka
University Graduate School of Medicine. Neurons were
cultured at a low density using conventional methods, as
reported previously [14]. A piece of the visual cortex was
removed from neonatal mice, enzymatically dissociated
with papain (20 U/ml), and triturated with a fire-polished
glass pipette. Neurons were plated on a previously pre-
pared glial feeder layer, and were grown in a solution
based on the Neurobasal A medium (GIBCO, Rockville,
MD, USA) supplemented with 5% B27 (GIBCO). All
experiments were carried out 14–24 days after plating.
Injection of plasmid cDNA of BDNF or NGF tagged with 
fluorescent proteins
The cDNAs of mouse BDNF or NGF tagged with GFP, CFP
or YFP at the C-terminus were provided by Dr. Masami
Kojima. Glass micropipettes were filled with Tris-ethyl-
ene-diamine-tetraacetic acid (EDTA) buffer (pH 8.0)
which contained cDNAs of BDNF-GFP, or -CFP (0.5–1
µg/µl), or NGF-GFP, or -YFP (0.5 µg/µl). Then cultured
neurons were placed on the stage of an inverted epifluo-
rescence microscope (TE300, Nikon, Tokyo, Japan), and
cDNAs were injected into the nucleus of a neuron through
a micropipette under visual control, using a micromanip-
ulator (MMO-202ND, Narishige, Tokyo, Japan), as
described previously [14].
Live-cell imaging
Neurons which expressed fluorescent protein-tagged
BDNF or NGF signals were observed using a 40 X /1.3 NA
oil immersion objective (Plan Flour, Nikon) attached to
the inverted epifluorescence microscope. The fluorescence
of GFP. CFP and YFP excited by light at the wavelength of
488, 434 and 514 nm was measured using a cooled CCD
camera (ORCA-ER, Hamamatsu Photonics, Hamamatsu,
Japan). Time-lapse recordings were carried out about 24 h
after the transfection, and sequential images were
acquired using a cooled CCD camera at about 30°C. The
exposure time was 1 or 2 s, the lapse of time was about 5
s, and the total time of recordings was 15–20 min. The
trafficking of BDNF was analyzed by tracking the posi-
tions of GFP fluorescence-positive vesicles in neurites as a
function of time. The analyses and animations of the data
were made using the AQUA COSMOS software (Hama-
matsu Photonics).
Immunocytochemistry
For immunocytochemical staining, neurons were fixed
with 4% paraformaldehyde (Sigma, St. Louis, MO, USA)
and 4% sucrose in Dulbecco's phosphate-buffered saline
(PBS) for 20 min at room temperature. The cells were
incubated with PBS containing 0.2% Triton-X (Sigma) for
5 min and blocked by 10% goat serum in PBS for 1 h at
37°. Then, anti-MAP2 monoclonal antibody (isotype:
IgG1, 1:250, Sigma), anti-BDNF polyclonal antibody (2
µg/µl, provided by Dr. Ritsuko Katoh-Semba), and anti-
GAD65 monoclonal antibody (isotype IgG2a, 1:100,
Chemicon, Temecula, CA, USA) were applied overnight at
4°. Endogenous BDNF was visualized by anti-rabbit sec-
ondary antibody conjugated with Alexa 546 (1:2000,
Molecular Probe). MAP2 and GAD65 were visualized by
anti-mouse secondary antibody conjugated with Alexa
647 or 350 (1:200, Chemicon), and by isotype-specific
secondary antibody conjugated with Alexa 546 (1: 2000,
Chemicon).
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